Search
Close this search box.

Fort Walton Medical Center offering antibody infusions for high-risk COVID patients

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors.  The first patient received the treatment on December […]

Fort Walton Beach Medical Center nurse administering the antibody infusion to a patient.

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors. 

The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion.

The FDA granted Emergency Use Authorization of bamlanivimab for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are high risk to develop severe COVID-19.  Fort Walton Beach Medical Center will provide the outpatient IV treatment for adults and adolescents age 12 and older.

High-risk conditions that may be eligible for this treatment include:

  • Obesity
  • 65+ years of age
  • Chronic kidney disease
  • COPD
  • Diabetes
  • Immunosuppressive disease
  • Heart disease
  • For children over the age of 12, sickle cell disease, neurodevelopmental disorders, and asthma are also among several additional considerations for eligibility.

“We’re committed to providing our patients, caregivers, and the communities we serve with the latest treatments in the fight against COVID-19 and are excited to bring this option to the tri-county area,” said Dr. Bob Kiskaddon, Chief Medical Officer for Fort Walton Beach Medical Center. “We will support all of our local hospitals in working closely with physicians and other providers across the communities we serve to provide treatment to patients who may benefit, per FDA guidelines.”

The medication supply is limited and based on availability. Patients will need a physician referral and meet FDA criteria prior to scheduling, according to the hospital.  The treatment is a one-time intravenous infusion over the course of one hour followed by an hour of monitoring.

bamlanivimab is not authorized for use for patients who:

  • Are hospitalized due to COVID-19
  • Require oxygen therapy due to COVID-19
  • Require supplemental oxygen for other conditions and require an increase in their oxygen requirement.

For more information on monoclonal antibody treatment for COVID-19, visit the Coronavirus Hub at www.fwbmc.com/covid-19.

Join the conversation...

Continue reading 👇

Community Comments

“Why is this something new at Hurlburt? I shutter thinking how easy it is to obtain visitor passes, but why was security so lax? We retired outta Hurlburt 10 years...”
Respond
“Where is this, how do you get there?”
Respond
“That's the problem with the far right. They never address the issue but attack the speaker on a personal basis. Have a wonderful day.”
Respond
“My father was a navigator on that very B26, tail number 666, on display. He was very proud of that aircraft and being in the 1st group of commandos at...”
Respond
“The fact that you feel the need to voice that opinion on this public site says a lot about you, Sir. Maybe it's YOU that could benefit from learning some...”
Respond
“Maybe Trump could learn some civility from this young man”
Respond
“They're here. Long line. But they're fast.”
Respond
“Came at 10:40AM 4/20 and there was no shredding vehicle.”
Respond
“Who was supposed to be watching him.....weird that no one's stating that and no updates on how he passed away.”
Respond
“Pick a place to drive to, the roads here suck”
Respond